Skip to content

Clinical trials

Phase 1 Autoimmune Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Phase: Phase 1 Country / region: Germany Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20131
20172
20201
20212
20222
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Not yet recruiting1
Recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany2
UCB Pharma2
Bioverativ, a Sanofi company1
Bristol-Myers Squibb1
Hutchmed1
Imcyse SA1
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company1
Novartis Pharmaceuticals1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
University of Erlangen-Nürnberg Medical School1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases12
Lupus Erythematosus, Systemic6
Immune System Diseases4
Connective Tissue Diseases3
Arthritis, Rheumatoid2
Blood Platelet Disorders2
Dermatomyositis2
Hematologic Diseases2
Lupus Nephritis2
Myositis2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.